Skip to content
TrialScanner

NCT03795389

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

Phase 1CompletedDMACLead

Registry record

Lead sponsor
DiaMedica Therapeutics Inc
Conditions
Chronic Kidney Disease; Chronic Kidney Disease, Stage 3 (Moderate); Chronic Kidney Disease, Stage 4 (Severe); Diabetes
Primary completion
Jul 21, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03795389 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.